Platelet-rich Plasma: Three Decades and Ongoing, Do We Have a Conclusion? - Egyptian Knowledge Bank

42956

Platelet-rich Plasma: Three Decades and Ongoing, Do We Have a Conclusion?

Article

Last updated: 04 Jan 2025

Subjects

Abstract

Blood components for non-transfusion uses have been the focus of researches in various clinical fields for the last thirty years. Platelet-rich plasma (PRP) can expedite healing, with minimal side effects. As a biologic autologous product, it is well-tolerated, and safe choice for many physicians and patients. Yet, no consensus has been reached regarding PRP preparation, needed volume, the use of an activator, number of sessions, and the period between the sessions in different clinical scenarios. Thus, further clinical studies are needed with higher level of evidence taking into consideration the optimization of these aspects. Up to date, there are many PRP preparation systems on the market with FDA clearance. Meanwhile, FDA has not attempted to regulate activated PRP. Determining the main bioactive components which are responsible for the clinical effects of PRP and the inter-individual variability of growth factors and cytokines production and the synergy of platelets count and growth factors will remain as major obstacles to achieve standardization of PRP. PRP is yet to become the standard of care; nevertheless, more clinical studies with longer periods of follow up to understand the best candidate and to determine the best ways to use it to improve healing; it may be an approved practice in the future.

DOI

10.21608/scumj.2019.42956

Keywords

platelet-rich plasma, growth factors, Platelets, applications, preparation methods

Authors

View Authors

First Name

Noha

Last Name

Kamel

MiddleName

Affiliation

Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Email

nkamel30@yahoo.com

City

Orcid

0000-0002-8990-2312

Volume

Article Issue

Related Issue

6743

Issue Date

2019-03-01

Receive Date

2019-07-30

Publish Date

2019-03-01

Page Start

Page End

Print ISSN

1110-6999

Online ISSN

2090-2581

Article File

SCUMJ_Volume 22_Issue 1_Pages 1-8.pdf

PDF . 220.3kB

Link

https://scumj.journals.ekb.eg/article_42956.html

Detail API

https://scumj.journals.ekb.eg/service?article_code=42956

Order

Publication Type

Journal

Publication Title

Suez Canal University Medical Journal

Publication Link

https://scumj.journals.ekb.eg/

MainTitle